Mieco pegs K-One wood pellet supply at RM100m a year
In a filing to Bursa Malaysia today, the group said the MoU, first announced on Aug 8 2025, sets a yearly minimum supply of 160,000 to 200,000 metric tonnes at a reference selling price of US$110 to US$150 per metric tonne.
Based on these parameters and the prevailing US dollar-ringgit exchange rate, the deal is worth around RM100 million per year.
Mieco had announced on Aug 8 that the five-year MOU will see K-One, a leading wood product importer in Korea, designated as Mieco's primary and preferential distributor for wood pellets in Korea, Japan and other agreed international markets.
The non-binding agreement also allows for possible exclusivity to certain buyers, subject to mutual consent.
The group said the collaboration marks its entry into the biomass fuel market, tapping into growing demand for wood pellets as a renewable energy source.
While the MOU is not expected to have an immediate material impact on earnings or net assets, it is envisaged to contribute positively to the group's future earnings. — TMR
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
30 minutes ago
- New Straits Times
Oil regains ground from two-month lows ahead of Trump-Putin meeting
TOKYO: Oil prices edged higher on Thursday, regaining ground after a sell-off in the previous session, with the upcoming meeting between US President Donald Trump and his Russian counterpart Vladimir Putin raising risk premiums in the market. Brent crude futures were up 28 cents, or 0.43 per cent, at US$65.91 a barrel at 0057 GMT, while US West Texas Intermediate crude futures rose 23 cents, or 0.37 per cent, to US$62.89. Both contracts hit their lowest in two months on Wednesday after bearish supply guidance from the US government and the International Energy Agency (IEA). Trump on Wednesday threatened "severe consequences" if Putin does not agree to peace in Ukraine. Trump did not specify what the consequences could be, but he has warned of economic sanctions if the meeting in Alaska on Friday proves fruitless. "The uncertainty of US-Russia peace talks continues to add a bullish risk premium given Russian oil buyers could face more economic pressure," Rystad Energy said in a client note. "How Ukraine-Russia crisis resolves and Russia flows change could bring some unexpected surprises." Another support for oil is that the expectation that the US Federal Reserve will cut rates in September is at close to 100 per cent after US inflation increased at a moderate pace in July. Treasury Secretary Scott Bessent said he thought an aggressive half-point cut was possible given recent weak employment numbers. The market is putting the odds of a quarter-percentage point cut at the Fed's September 16-17 meeting at 99.9 per cent, according to the CME FedWatch tool. Lower borrowing rates would drive demand for oil. The dollar was hovering near multi-week lows against the euro and sterling on Thursday as traders ramped up bets for the Fed to resume cutting interest rates next month. Oil prices were kept in check as crude inventories in the United States unexpectedly rose by 3 million barrels in the week ended on August 8, according to the US Energy Information Administration on Wednesday, against expectations in a Reuters poll for a 275,000-barrel draw. Also, holding oil back was an International Energy Agency forecast that 2025 and 2026 world oil supply would rise more rapidly than expected, as the Organisation of the Petroleum Exporting Countries and its allies, together known as OPEC+, increase output and production from outside the group grows.
New Straits Times
30 minutes ago
- New Straits Times
Dollar in doldrums as Fed rate-cut bets build
TOKYO: The dollar languished near multi-week lows against the euro and sterling on Thursday as traders ramped up bets for the Federal Reserve to resume cutting interest rates next month. Rising expectations for Fed easing combined with increasing institutional cryptocurrency investment sent bitcoin powering to a fresh record peak. The dollar index, which measures the currency against the euro, sterling and four other major peers, was steady at 97.704 as of 0002 GMT. It dropped some 0.8 per cent over the previous two sessions, having dipped to 97.626 on Wednesday for the first time since July 28. The euro edged up to US$1.1713, nearing Wednesday's high of US$1.1730, a level last seen on July 28. Sterling rose to US$1.3586 for the first time since July 24. Against Japan's currency, the greenback lost 0.3 per cent to 146.95 yen. Fed rhetoric has turned overall more dovish of late, amid signs of a cooling labour market and with President Donald Trump's tariffs not adding to price pressures in a significant way as of yet. Traders see a Fed rate cut on September 17 as a near certainty, according to LSEG data, and even lay around 7 per cent odds on a super-sized half-point reduction. "For the markets, it's not even a matter of if the Fed cuts interest rates in September, it's a question of how much," said Kyle Rodda, an analyst at "Signs of a downturn in the labour market have pushed futures to bake in a series of rate cuts before the end of the year." On Wednesday, Treasury Secretary Scott Bessent called for a "series of rate cuts," and said the Fed could kick off the policy rate easing with a half-point cut. Trump has repeatedly criticised Fed Chair Jerome Powell for not easing rates sooner. A weaker dollar, the spectre of political interference in US monetary policy, and the increase in investor risk appetite amid Fed easing prospects all converged to buoy bitcoin to its first record peak since July 14, pushing as high as US$123,674.71 in the latest session. Bitcoin was already underpinned by increased institutional money flows this year in the wake of a spate of regulatory changes spearheaded by Trump, who has billed himself the "cryptocurrency president." In the latest move, an executive order last week paved the way to allow crypto assets in 401(k) retirement accounts. "Corporate treasuries like MicroStrategy and Block Inc. continue to buy bitcoin," said IG analyst Tony Sycamore.
New Straits Times
2 hours ago
- New Straits Times
US pharma tariffs likely weeks away, sources say
WASHINGTON: The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new sector-specific US tariffs likely remains weeks away, four official and industry sources said, later than initially promised as he focuses on other matters. Commerce Secretary Howard Lutnick had said in April when the review of whether reliance on foreign drug production threatens US national security was launched that he anticipated that it would conclude between mid-May and mid-June. Global pharmaceutical companies are bracing for the outcome of the investigation, which will usher in sector-specific tariffs that Trump has said could start small and eventually rise to 250 per cent. The Republican president said as recently as last week that his plan relies on phased-in tariffs, giving drugmakers time to increase manufacturing in the United States as he pushes to alter what he says are global trade distortions in many industries. One government official in Europe and a source with knowledge of the White House process, as well as two sources at European drug firms familiar with the process, told Reuters that the report and tariffs announcement was not imminent and likely weeks away. These sources spoke on condition of anonymity. A White House spokesperson, asked about media reporting indicating that the results of the probe could be several weeks away, cautioned that such reports were pure speculation unless confirmed by the White House. The spokesperson declined to give further details about the timing of the pharma probe or one involving semiconductors. The investigation is examining pharmaceutical imports ranging from finished prescription drugs to active pharmaceutical ingredients, called APIs, and other raw materials, with the results to be disclosed in a Commerce Department report. Lutnick said last month the tariff plan that will be based on the report would be completed by the end of July. Lutnick then said on July 29 it would be two more weeks. The investigation was launched under Section 232 of the Trade Expansion Act of 1962. While the investigation is ongoing, the pharmaceutical sector has been exempted from the sweeping tariffs imposed by the Trump administration. The United States has reached bilateral trade deals with the UK, Japan, South Korea and the European Union that promised more favorable terms for their pharma exports than those expected to be levied on the sector globally. A European government official said that an announcement before the end of August appears unlikely but cautioned that the timeline could shift depending on other developments. A source at a European drugmaker said the Trump administration is focused on the US-Russia summit in Alaska on Friday and therefore no announcement is expected this week. The source familiar with the White House process said that announcement is unlikely to come this week given other priorities. That source and one other source said that they expect the Trump administration to announce the results of its national security investigation into semiconductors first, followed by the pharma announcement, putting it a few weeks away. The Section 232 provision authorizes the president to adjust imports - including imposing tariffs - if a category of goods is being imported into the United States in quantities that "threaten or impair the national security." Medical goods historically have been spared from trade wars due to the potential harm to patient access, and drugmakers have said tariffs could undercut other health policy goals outlined by the Trump administration, including lowering drug prices. US tariffs on imported pharmaceutical products would mark the latest in a series of sectoral tariffs announced by the administration, following metals and cars, that some economists have predicted will drive up costs for American consumers.
